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Abstract 
The electronic structure of charybdotoxin (ChTX), a scorpion venom peptide that is 
known to act as a potassium channel blocker, is investigated with the aid of quantum 
mechanical calculations. The dipole moment vector (=145 D) of ChTX can be stirred by 
the full length KcsA potassium channel’s macrodipole (=403 D) thereby assuming the 
proper orientation before binding the ion channel on the cell surface. The localization of 
the frontier orbitals of ChTX has been revealed for the first time. HOMO is localized on 
Trp14 while the three lowest-energy MOs (LUMO, LUMO+1, and LUMO+2) are 
localized on the three disulfide bonds that characterize this pepetide. An effective way 
to engineer the HOMO-LUMO (H-L) gap of ChTX is that of replacing its Trp14 residue 
with Ala14 whereas deletion of the LUMO-associated disulfide bond with the insertion 
of a pair of L--aminobutyric acid residues does not affect the H-L energy gap. 
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1. Introduction 
The venom of scorpions contains a pool of several globular peptides (mini-proteins) 
which have the ability to bind a variety of ion (Na+, K+, Ca2+) channels located on the 
cell surface of the organism under attack [1-3]. Upon binding to the extracellular side of 
the ion channel’s pore, the ions’ flux through the membrane is blocked and this event 
triggers a cytokine-mediated inflammatory response which produces local pain and can 
escalate up to respiratory failure and death [4]. In 1982 the first scorpion venom 
peptide, noxiustoxin, was isolated from the venom of the scorpion Centruroides noxius 
[5]. Soon after, many other scorpion toxins were identified and structurally 
characterized (mainly by solution NMR spectroscopy). To date the 3D structures of 
more than one hundred scorpion venom peptides have been characterized and their 
atomic coordinates deposited into the Protein Data Bank (PDB) [6]. Beside their 
toxicity, these peptides might find useful applications as drugs in the treatment of 
immunological diseases [7,8] and as insecticides [9]. 
Among the venom peptides investigated so far, the 37 amino acid (AA) residue 
charaybdotoxin (ChTX) has played a special role as channel blocker. ChTX was 
discovered by Miller et al. [10] in 1985 after its isolation from the venom of scorpion 
Leiurus quinquestriatus. The molecular structure of ChTX was subsequently 
characterized by Bontems et al. [11,12] using NMR spectroscopy. As shown in Figure 
1(a), ChTX is made of a small -helix (containing 10 AA residues) linked to a 
three-stranded antiparallel -sheet via a pair of disulfide bonds (cystine moieties). A 
third disulfide bond connects the -sheet to a loop that protrudes from the -helix. This 
characteristic  motif is widely conserved among scorpion toxins. The N-terminal 
residue of ChTX is the neutral pyroglutamic acid (PGA) or pyrrolidone carboxylic acid 
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(denoted to as Z in Figure 1(b)), an uncommon amino acid which is known as being an 
N-terminal blocker that arises from the cyclization of N-terminal glutamine residues 
[13]. The C-terminal residue of ChTX is a serine (Ser37) which is linked via its C atom 
to the negatively-charged carboxylate group. 
 
 
Figure 1. (a) Ribbon representation of the 3D structure of ChTX (standard orientation). 
(b) Primary structure of ChTX with the corresponding elements of secondary structure 
and disulfide bonds between cytosine (C) residues. The localization of the HOMO on 
Trp14 (W) and LUMO on Cys13-Cys35 (C) residues is also shown along with the formal 
charge on each amino acid side chain. 
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In 2005, almost twenty years after the discovery of ChTX, Yu et al. [14] determined the 
structure of the complex between ChTX and KcsA potassium channel by using NMR 
spectroscopy. The authors introduced six mutations into KcsA so as to increase its 
affinity toward ChTX. The experimental structure of the complex (PDB id 2A9H) 
evidenced for the first time the formation of important contacts among the AA residues 
of these two proteins. In particular, it emerged that a charged lysine residue (K27) 
located on the -sheet of ChTX is found being inserted into the ion channel’s selectivity 
filter thereby blocking the passage of K+ ions. Although no other experimental 
structure of venom peptide/channel complex is known, the 3D models of the complexes 
between ChTX and other potassium channels (Kc1.2, BK) have been investigated 
computationally using a combination of homology modeling, docking, and molecular 
dynamics (MD) simulation [15-17]. 
As far as the molecular recognition of K channels is concerned, the permanent dipole 
moment of these peptides has been suggested to play an important role in determining 
the orientation of the peptide when it approaches its target ion channel on the cell 
surface [16]. In this regard, a recent MD simulation study by Chen and Kuyukak [17] 
indicated that upon unbinding of ChTX from KcsA the dipole moment vector of the 
peptide aligns with the dipole vector of the ion channel whereas in the ChTX:KcsA 
complex, whereby strong electrostatic interactions are established at the interface, the 
two dipole vectors form an angle of 40°. 
In this study we investigate the electronic structure of ChTX using quantum 
mechanical calculations [18]. Along with the frontier orbitals and distribution of 
electronic charge in each amino acid side chain, we wish to provide a quantitative 
estimate of the magnitude and orientation of the permanent dipole moment of this 
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important peptide. So far, and to the best of our knowledge, the magnitude of the dipole 
moment of ChTX is as yet unknown. Using classical force fields Yu et al. [15] showed 
that the dipole vector of ChTX and those of five other venomous peptides are oriented 
toward their -sheet regions in the corresponding molecular structures but the 
magnitude of each dipole moment was not given. On the other hand, Ireta et al. [19] 
performed total energy pseudopotential calculations to investigate the electronic 
structure of ChTX using the experimental NMR structure of Bontems et al. [11,12]. 
With the aid of a band structure approach they obtained useful information on the 
electrostatic potential and chemical softness but the dipole moment was not 
investigated. It is therefore timely to quantitatively characterize the dipole moment of 
ChTX also in the light of recent theoretical results of the author concerned with the 
dipole moment of KcsA potassium channel [20]. 
 
2. Computational details 
The solution NMR structure of ChTX determined by Bontems et al. [11,12] and whose 
atomic coordinates are stored in the PDB (accession number 2CRD) was employed here. 
Of the 12 model conformers that are included in the PDB file, the first one was selected. 
Hydrogen atoms were same as those in the experimental structure. Quantum 
mechanical calculations were performed with the MOPAC2009 software package [21] 
of Stewart which contains the MOZYME module [22] and novel PM6 parameters [23] 
for the QM treatment of proteins [24]. First, we determined the net charge of ChTX by 
computing its Lewis structure which is made of 585 -type bonds, 179 lone-pairs, and 
55 -type bonds. There are seven positive charges and two negative charges which 
contribute a total net charge of +5. Hence, the net charge is same as that of the ChTX 
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model of Chen and Kuyukak [17]. The resulting atomic model of ChTX contains 577 
atoms (empirical formula: C176H282N57O55S7) and 41 peptide linkages. Next we 
optimized the geometry of this protein. Because ChTX is a small peptide (37 amino acid 
residues), the canonical molecular orbital (MO) optimization routines of MOPAC2009 
were employed in combination with the COSMO solvation model of Schüürmann [25] 
(for water the recommended value of =78.4 for the dielectric constant was employed). 
The level of theory employed in this study is thus denoted to as PM6-SCF-MO-COSMO. 
The JMol software [26] was employed for the visualization of MOs while the dipole 
moment vector was visualized with a local software. 
 
3. Results and discussion 
3.1 Geometry 
The geometry of ChTX optimized at the PM6-SCF-MO-COSMO level of theory is shown 
in Figure 2. On the left side of Figure 2 is depicted the optimized structure of CT in the 
standard orientation (see Figure 1) while on the right side of Figure 2 the structure has 
been rotated by 90° about the vertical axis passing through Lys31. As seen from this 
figure, a number of positively charged amino acid residues are sticking out from the 
protein, namely Lys31 and Lys 32 on the top, Lys27 and Arg34 in the middle, and 
Lys11, Arg19, and Arg25 at the bottom. Among these charged amino acids, Lys27 
forms an H-bond with the oxygen atom of Tyr36 and the nitrogen atom of Arg34. The 
latter group interacts also with the oxygen lone-pair of Tyr36 thereby contributing to 
the stabilization of this Lys27/Arg34/Tyr36 triad, as depicted in Figure 3(a). Arg25 
forms a salt bridge with the C-terminal carboxylate group where Ser37 is located, as 
displayed in Figure 3(b). Hence, it appears that the remaining lysine and arginine 
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chains are likely being involved in interactions with the solvent (here assumed as a 
continuum). 
 
Figure 2. Optimized geometry of ChTX shown in the standard orientation (left) and 
after a 90° rotation about the axis passing through Lys31. Disulfide bonds (cystine 
moieties) are circled (left) and selected amino acids chains are labeled. 
 
Several intramolecular H-bonds of type C=O∙∙∙H–N are established among peptide 
units in the -helix and -sheet elements of ChTX. In addition, the carbonyl and NH 
groups of two consecutive peptide linkages form H-bonds with the NH moiety of Trp14, 
as shown in Figure 3(c). These H-bonds are likely to stabilize the orientation of Trp14 
on the protein surface. Furthermore, the carbonyl group of a peptide linkage forms an 
H-bond with the N-terminal PGA residue, as shown in Figure 3(d). Of the three 
disulfide bonds, highlighted by circles in Figure 2, only one (Cys7-Cys28) is exposed to 
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the solvent whereas the other two (Cys13-Cys33 and Cys17-Cys35) are buried inside 
the protein. The average S–S bond length computed here at the SCF-MO-PM6-COSMO 
level of theory corresponds to ~2.05 Å which is in excellent agreement with the 
experimental value of 2.0472(4) Å determined by an x-ray crystallographic analysis of 
L-cystine at 110 K [27]. It is worth noticing that the placement of the three disulfide 
bonds in the central part of the protein confers substantial rigidity to the whole tertiary 
structure of ChTX. 
 
Figure 3. Details of the intramolecular contacts in ChTX: (a) the Lys27/Arg34/Tyr36 
triad and distances between heteroatom pairs; (b) salt bridge between Arg25 and the 
C-terminal carboxylate group; (c) H-bonds between Trp14 and a nearby pair of peptide 
linkages; and (d) H-bond between PGA and a nearby peptide linkage. Distances in Å. 
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3.2 Electronic structure 
We analyzed the frontier orbitals of ChTX which are depicted in Figure 4. The two 
highest-occupied molecular orbitals, HOMO and HOMO-1, are localized on the Trp14 
residue while HOMO-2 is localized on one disulfide bond. On the other hand, the 
lowest-unoccupied molecular orbitals, LUMO, LUMO+1, and LUMO+2, are localized 
on the disulfide bonds of Cys13-Cys33, Cys7-Cys28, and Cys17-Cys35, respectively, as 
shown in Figure 4.  
 
 
Figure 4. Frontier molecular orbitals of ChTX (standard orientation). 
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Interestingly, an analogous localization pattern of the frontier orbitals was found also 
in a recent quantum mechanical study of human erythropoietin (huEPO) [28] where 
HOMO and HOMO-1 are localized on two tryptophan residues (Trp51 and Trp64) while 
LUMO and LUMO+1 are localized on two disulfide bonds (Cys7-Cys161 and 
Cys29-Cys33). Further, also the HOMO of the SH2 domain of p56lck tyrosine kinase is 
localized on a tryptophan residue (Trp127) [29]. Hence, removal of electrons from these 
proteins should occur through the oxidation of their tryptophan residues while the 
addition of electrons would involve the reduction of their disulfide bonds. Among the 
three disulfide bonds of ChTX, we notice from Figure 4 that Cys13-Cys33, where the 
LUMO is localized, is buried into the protein while Cys7-Cys28 bearing LUMO+1 is 
exposed to the solvent and hence it is the one more likely being subject to chemical 
reduction. 
The computed HOMO-LUMO (H-L) gap of ChTX corresponds to 6.676 eV. This is 
slightly larger than the H-L gap of 5.534 eV computed (at the PM5-COSMO level) for 
the native structure of huEPO [28] but smaller than the H-L gap of ubiquitin which 
corresponds to 8.346 eV [30]. We have shown that it is possible to modify the H-L gap of 
huEPO by mutation of selected amino acid residues [28]. Another possibility for 
engineering the H-L gap is that of deleting disulfide bonds. Both strategies are feasible 
in the case of ChTX as a number of mutants have been investigated by Miller’s group 
[31,32] while Song et al. [33] have been able to delete one disulfide bond (Cys13-Cys33) 
by inserting two L--aminobutyric acid residues (Cys13-Aba and Cys33-Aba). The 
structure of the resulting two-disulfide derivative of ChTX, termed CHABII, was 
determined by solution NMR spectroscopy and the atomic coordinates of 30 conformers 
deposited in PDB (code 1BAH). We have fully optimized the geometry of the first 
conformer (denoted to as model 1 inside the PDB file) at the SCF-MO-PM6-COSMO 
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level of theory and the computed H-L gap corresponds to 6.666 eV, which is only 0.01 
eV smaller than that of the native peptide. Because the three lowest-energy MOs of 
ChTX (localized on the three disulfide bonds) are very close in energy, the deletion of 
one disulfide bond is not effective in changing the H-L gap of the peptide. A more 
effective way of engineering the H-L gap of ChTX would be that of replacing the Trp14 
residue, where HOMO is localized, with a non-aromatic residue such as alanine. We 
therefore computed the electronic structure of the Trp14Ala mutant of ChTX and 
obtained an H-L gap of 7.266 eV, which is 0.59 eV larger than that of the native peptide. 
Hence, replacing the residue where HOMO is localized represents an effective strategy 
for engineering the H-L gap of this protein. 
 
Figure 5. Dipole moment vector of ChTX with the peptide in the standard orientation 
(left) and oriented with the -helix above the -sheet. The arrow’s center is placed on 
the center of mass of the protein. 
 
3.3 Dipole moment 
The dipole moment of ChTX, which has a magnitude of 145 D, was computed with 
respect to the center of mass of the protein [21]. Figure 5 shows the dipole moment 
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vector of ChTX as obtained at the PM6-SCF-MO-COSMO level of theory. As seen from 
this figure, the dipole vector forms an angle of ~50° with the -helix while the positive 
tip is oriented towards the -sheet. It has been suggested that when ChTX approaches 
a K channel such as KcsA, the peptide will align its dipole moment vector with respect 
to the dipole of the channel [17]. Accordingly, quantum mechanical calculations 
recently performed by the author indicated that the truncated form of KcsA (TF-KcsA) 
has a dipole moment of 272 D while the full length (FL-KcsA) structure possesses a 
dipole of magnitude 403 D [20]. In both cases the dipole moment vector is aligned along 
the fourfold axis of the ion channel and with the positive head pointing toward the 
internal part of the cell while the negative end is located on the extracellular region. 
These results indicate that the macrodipole of Kcsa is large enough to provoke the 
alignment of ChTX dipole thereby assisting the scorpion venom peptide in positioning 
its -sheet toward the channel’s mouth, as seen in the experimental structure depicted 
in Figure 6. 
Upon binding, however, stronger electrostatic interactions are formed at the 
ChTX/channel interface which provoke the bending of ChTX thereby changing the 
relative orientation of the two dipoles. In this regard, Chen and Kuyukak [17] found 
that the dipole vectors of the two proteins form an angle of 40° once they are tightly 
bonded in the complex. By placing the structure of ChTX above the KcsA mouth and 
adjusting its orientation according to that in the experimental structure of the complex, 
we were able to determine an angle of ~50° between the dipole moments of the two 
proteins. This result is in excellent agreement with that of Chen and Kuyukak [17] 
especially if one takes into account that the formation of the ChTX:KcsA complex will 
modify the orientation of the amino acid chains that are located at the interface with 
respect to the free peptide. Also, one has to consider that the large dipole moments of 
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TF-KcsA (=272 D) and FL-KcsA (=403 D) will polarize the electronic charge density 
of ChTX thereby optimizing the interaction of these two molecules in the complex. 
 
 
Figure 6. Comparison between the dipole moments of ChTX and KcsA potassium 
channel (right). ChTX is oriented as in the experimental structure of the ChTX:KcsA 
complex (left) but moved away from the channel’s mouth. 
 
4. Conclusions 
We investigated the electronic structure of ChTX, a scorpion venom peptide which is 
known to act as a potassium channel blocker, with the aid of quantum mechanical 
calculations. The results indicate that the dipole moment vector of ChTX is oriented 
toward the -sheet while forming an angle of ~50° with the -helix. The magnitude of 
the dipole moment (=145 D) is such that it can be stirred by the macrodipole of KcsA 
thereby properly orienting the peptide before binding. Furthermore, the location of the 
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frontier orbitals of ChTX has been revealed for the first time and an effective strategy 
for engineering the HOMO-LUMO gap of this scorpion peptide has been proposed. 
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